# Compassionate Use of CAR T Cells Targeting the CD19 Antigen and Containing the Inducible Caspase 9 Safety Switch

> **NCT03594162** · — · NO_LONGER_AVAILABLE · sponsor: **UNC Lineberger Comprehensive Cancer Center**

## Conditions studied

- Acute Lymphoblastic Leukemia
- Immune System Diseases
- Immunoproliferative Disorders

## Interventions

- **DRUG:** iC9-CAR19 cells
- **DRUG:** AP1903
- **DRUG:** Cyclophosphamide
- **DRUG:** Fludarabine

## Key facts

- **NCT ID:** NCT03594162
- **Lead sponsor:** UNC Lineberger Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2021-12-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03594162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03594162, "Compassionate Use of CAR T Cells Targeting the CD19 Antigen and Containing the Inducible Caspase 9 Safety Switch". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03594162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*